Definitive Management of Presumed Synchronous Early Stage Non-Small Cell Lung Cancers: Outcomes and Utility of Stereotactic Ablative Radiation Therapy
- 7 February 2020
- journal article
- research article
- Published by Elsevier BV in International Journal of Radiation Oncology*Biology*Physics
- Vol. 107 (2), 261-269
- https://doi.org/10.1016/j.ijrobp.2020.02.001
Abstract
No abstract availableFunding Information
- National Institutes of Health (CA016672)
- China Scholarship Council
This publication has 37 references indexed in Scilit:
- Stereotactic body radiation therapy for early-stage non-small cell lung cancer: Executive Summary of an ASTRO Evidence-Based GuidelinePractical Radiation Oncology, 2017
- Surgical treatment is an effective approach for patients with synchronous multiple primary lung cancersJournal of Cancer Research and Therapeutics, 2017
- Use of stereotactic body radiation therapy for medically inoperable multiple primary lung cancerJournal of Medical Imaging and Radiation Oncology, 2012
- Stereotactic Body Radiation Therapy for Inoperable Early Stage Lung CancerJAMA, 2010
- Special Treatment Issues in Lung CancerSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2007
- Prognosis of Resected Non-Small Cell Lung Cancer Patients with Intrapulmonary MetastasesJournal of Thoracic Oncology, 2007
- Stereotactic body radiotherapy for bilateral primary lung cancers: The Indiana University experienceInternational Journal of Radiation Oncology*Biology*Physics, 2006
- Multiple Primary Lung CancersThe Thoracic and Cardiovascular Surgeon, 1994
- Multiple primary lung carcinomas: Prognosis and treatmentThe Annals of Thoracic Surgery, 1991
- Second primary lung cancer: importance of long term follow up.Thorax, 1989